News in the Life Sciences Industry

STOCKHOLM, March 2, 2020 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) announces that new data from the completed phase Ia study with MIV-818 will be presented at the R&D day hosted by the company today, from 2 pm - 4.30 pm (CET).

LUND, Sweden, March 2, 2020 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, announced today that the Swedish version of the Annual Report 2019 is available on the company... Read more ››

STOCKHOLM, Feb. 28, 2020 /PRNewswire/ -- The number of shares and votes in Cantargia AB (publ) has changed due to the recently completed directed share issue (for further information, see the company's press release on 19 February 2020).

STOCKHOLM, Feb. 28, 2020 /PRNewswire/ -- According to a new survey from rare disease company Sobi, 28 per cent of people living with a rare condition, and their caregivers, say the disease has caused a relationship to end. 41 percent state that a rare disease has prevented them from starting... Read more ››

LUND, Sweden, Feb. 27, 2020 /PRNewswire/ -- "We are proud that we have delivered on our goals for the year and feel confident that we will continue to do so in 2020, with a number of important milestones approaching. Our cooperation with Merck & Co is our second large pharma collaboration... Read more ››

STOCKHOLM, Feb. 27, 2020 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company is donating the medical device AnaConDa and accessories for anti-epidemic use and evaluation of the effects of inhalation sedation with AnaConDa on severely ill Corona... Read more ››

STOCKHOLM, Feb. 27, 2020 /PRNewswire/ -- Cantargia AB's ("Cantargia") full year report for 2019 is now available on the company's web page Read more ››

STOCKHOLM, Feb. 27, 2020 /PRNewswire/ -- Hygiene and health company Essity has signed an agreement to acquire 75% of the Swedish medical solutions company ABIGO Medical AB. The company as a whole is valued at SEK 900m on a debt-free basis. ABIGO Medical AB develops, manufactures and markets... Read more ››

STOCKHOLM, Feb. 25, 2020 /PRNewswire/ -- Cantargia AB (publ) (Cantargia) today announced it has appointed Dr. Ignacio Garcia-Ribas as Chief Medical Officer (CMO) of Cantargia from March 1, 2020. He will be a member of the Executive Management and have a key role in the advancement of the... Read more ››

STOCKHOLM, Feb. 25, 2020 /PRNewswire/ -- Elekta (EKTA-B.ST) invites analysts and investors to a meeting on April 4, in conjunction with the Annual Meeting of the European Society for Radiation Oncology (ESTRO), in Vienna, Austria.

LUND, Sweden, Feb. 25, 2020 /PRNewswire/ -- Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the Company's management team will participate in the following upcoming investor conferences:

STOCKHOLM, Feb. 25, 2020 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced the publication of scientific data on the mechanism of action of cobitolimod, the company's lead drug candidate in development for the treatment of moderate to severe ulcerative colitis. The paper,... Read more ››

STOCKHOLM, Feb. 25, 2020 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) invites investors, analysts and the media to a R&D Day in Stockholm, Monday March 2, 2020, at 14:00 to 16:30 CET.